Ligand id: 8500

Name: danirixin

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 4
Rotatable bonds 6
Topological polar surface area 115.91
Molecular weight 441.09
XLogP 4.44
No. Lipinski's rules broken 0

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Danirixin is being evaluated in Phase II clinical trials as a potential anti-inflammatory treatment for the neutrophil-mediated airway inflammation associated with chronic obstructive pulmonary disease (COPD) and influenza Infection.